CSIMarket
 


Vbi Vaccines Inc  (VBIV)
Other Ticker:  
 
 

Vbi Vaccines Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Vbi Vaccines Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 40.26, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2023. Average receivable collection period, for the Vbi Vaccines Inc in Sep 30 2023 quarter, has decreased to 9 days, compared to 29 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 32 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 340, from overall ranking in the second quarter 2023 at 4060.

What is Receivable Turnover Ratio?
What is Vbi Vaccines Inc Selling?


What is Receivable Turnover Ratio?




VBIV Receivables Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Receivable Change 167.42 % -41.48 % 175.49 % 1075 % 266.67 %
Y / Y Revenue Change 1989.59 % 108.09 % 284.92 % 261.73 % 196.26 %
Receivable Turnover Ratio (TTM) 40.26 12.39 8.98 9.35 9.23
VBIV's Total Ranking # 340 # 4060 # 3455 # 1157 # 1144
Average receivable collection period 9 29 41 39 40
Seq. Receivable Change 346.84 % -71.89 % 198.94 % -28.79 % -2.22 %
Seq. Revenue Change 820 % 48.45 % 65.53 % -7.57 % -8.38 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 18
Healthcare Sector # 33
Overall Market # 340

Receivable Turnover Ratio Statistics
High Average Low
44.68 14.72 4.71
(Jun 30 2019)   (Jun 30 2018)






Financial Statements
Vbi Vaccines Inc's Accounts Receivable $ 0 Millions Visit VBIV's Balance sheet
Vbi Vaccines Inc's Sales TTM $ 8 Millions Visit VBIV's Income Statement
Where are VBIV's Sales coming from? Visit VBIV's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VBIV's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for VBIV's Competitors
Receivables Turnover Ratio for VBIV's Suppliers
Accounts Receivables Turnover Ratio for VBIV's Customers

You may also want to know
VBIV's Growth Rates VBIV's Roa VBIV's Inventory Turnover Ratio VBIV's Dividend Comparisons
VBIV's Profitability Ratios VBIV's Roi VBIV's Asset Turnover Ratio VBIV's Dividend Growth
VBIV's Valuation Ratios VBIV's Roe VBIV's Financial Strength Ratios VBIV's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Scynexis Inc   62.10 $ 135.869  Millions$ 2.188  Millions
Clearday Inc   61.82 $ 7.543  Millions$ 0.122  Millions
Agenus Inc  61.81 $ 100.897  Millions$ 1.632  Millions
Zeo Scientifix Inc   61.17 $ 4.558  Millions$ 0.075  Millions
Airsculpt Technologies Inc   59.60 $ 189.013  Millions$ 3.171  Millions
Brookdale Senior Living Inc   57.81 $ 2,949.838  Millions$ 51.031  Millions
Ambrx Biopharma Inc   53.68 $ 8.602  Millions$ 0.160  Millions
Marpai Inc   50.33 $ 36.077  Millions$ 0.717  Millions
Wave Life Sciences Ltd   48.85 $ 85.488  Millions$ 1.750  Millions
Janux Therapeutics Inc   45.16 $ 8.467  Millions$ 0.188  Millions
Sangamo Therapeutics Inc   44.25 $ 201.420  Millions$ 4.552  Millions
Aclaris Therapeutics Inc   44.03 $ 21.432  Millions$ 0.487  Millions
Aridis Pharmaceuticals Inc   41.46 $ 22.359  Millions$ 0.539  Millions
Vivos Therapeutics Inc   41.42 $ 13.803  Millions$ 0.333  Millions
Mei Pharma Inc   40.65 $ 105.383  Millions$ 2.592  Millions
Vbi Vaccines Inc  40.26 $ 8.122  Millions$ 0.202  Millions
Lineage Cell Therapeutics Inc   40.10 $ 8.772  Millions$ 0.219  Millions
Spero Therapeutics Inc   38.72 $ 77.699  Millions$ 2.007  Millions
Lifemd Inc   38.63 $ 133.842  Millions$ 3.465  Millions
Neptune Wellness Solutions Inc   38.14 $ 43.724  Millions$ 1.146  Millions
Nature s Sunshine Products inc   37.58 $ 437.245  Millions$ 11.635  Millions
Electrocore Inc   37.19 $ 13.399  Millions$ 0.360  Millions
Sonida Senior Living Inc   35.91 $ 249.127  Millions$ 6.938  Millions
Fusion Pharmaceuticals Inc   34.91 $ 2.208  Millions$ 0.063  Millions
China Pharma Holdings Inc   34.57 $ 7.783  Millions$ 0.225  Millions
23andme Holding Co  31.43 $ 269.726  Millions$ 8.583  Millions
Inmed Pharmaceuticals Inc   31.18 $ 5.287  Millions$ 0.170  Millions
Nektar Therapeutics  28.21 $ 88.260  Millions$ 3.129  Millions
Stoke Therapeutics Inc   28.20 $ 9.248  Millions$ 0.328  Millions
Eargo Inc   27.36 $ 39.694  Millions$ 1.451  Millions

Date modified: 2023-12-03T16:25:46+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com